We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
-1.37%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$18.4B
AUM Growth
-$521M
(-2.8%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
24.68%
Holding
1,660
New
130
Increased
801
Reduced
372
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$61.5M |
| 2 |
Merck
MRK
|
+$58.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$56.5M |
| 4 |
Lockheed Martin
LMT
|
+$49.7M |
| 5 |
Chubb
CB
|
+$49.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$76.2M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.4M |
| 3 |
Goldman Sachs
GS
|
+$60.9M |
| 4 |
Intuit
INTU
|
+$57.5M |
| 5 |
Deere & Co
DE
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 12.63% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Royalty Pharma
RPRX
$25.3B
| $443K | ﹤0.01% |
11,363
| – | – |
|
1252
FS Bancorp
FSBW
$320M
| $441K | ﹤0.01% |
14,226
+8,051
| +130% | +$262K |
|
1253
Orrstown Financial Services
ORRF
$838M
| $440K | ﹤0.01% |
19,186
+5,981
| +45% | +$145K |
|
1254
HEICO Corp
HEI
$51.4B
| $439K | ﹤0.01% |
2,860
| – | – |
|
1255
Duluth Holdings
DLTH
$159M
| $437K | ﹤0.01% |
35,700
+22,922
| +179% | +$321K |
|
1256
Palantir
PLTR
$413B
| $437K | ﹤0.01% |
31,794
-374
| -1% | -$4.99K |
|
1257
EverQuote
EVER
$906M
| $436K | ﹤0.01% |
26,974
| – | – |
|
1258
SoFi Technologies
SOFI
$23.7B
| $435K | ﹤0.01% |
+46,074
| New | +$529K |
|
1259
Veracyte
VCYT
$3.8B
| $434K | ﹤0.01% |
15,728
| – | – |
|
1260
Amphastar Pharmaceuticals
AMPH
$916M
| $432K | ﹤0.01% |
12,027
-17,938
| -60% | -$509K |
|
|
HSII
1261
DELISTED
Heidrick & Struggles
HSII
| $432K | ﹤0.01% |
10,926
-2,274
| -17% | -$96.1K |
|
1262
Legend Biotech
LEGN
$4.01B
| $432K | ﹤0.01% |
+11,895
| New | +$470K |
|
1263
Modine Manufacturing
MOD
$10.4B
| $431K | ﹤0.01% |
47,869
+145
| +0.3% | +$1.43K |
|
1264
Ormat Technologies
ORA
$6.65B
| $431K | ﹤0.01% |
5,267
-782
| -13% | -$57.2K |
|
1265
Atea Pharmaceuticals
AVIR
$420M
| $429K | ﹤0.01% |
59,424
+1,463
| +3% | +$9.94K |
|
1266
Boston Properties
BXP
$11.1B
| $429K | ﹤0.01% |
3,328
-312
| -9% | -$37.8K |
|
|
NBP
1267
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $429K | ﹤0.01% |
26,425
+12,812
| +94% | +$328K |
|
1268
Mercury Insurance
MCY
$6.07B
| $429K | ﹤0.01% |
7,808
+254
| +3% | +$13.7K |
|
1269
Upstart Holdings
UPST
$3.03B
| $428K | ﹤0.01% |
+3,922
| New | +$452K |
|
|
CHX
1270
DELISTED
ChampionX
CHX
| $426K | ﹤0.01% |
17,388
| – | – |
|
|
DMC
1271
Del Monte Corp
DMC
$1.45B
| $426K | ﹤0.01% |
16,428
-314
| -2% | -$8.53K |
|
1272
America Movil
AMX
$71.2B
| $425K | ﹤0.01% |
20,084
-43,591
| -68% | -$842K |
|
1273
Ocular Therapeutix
OCUL
$2.02B
| $423K | ﹤0.01% |
85,424
+55,346
| +184% | +$307K |
|
1274
Fiverr
FVRR
$339M
| $422K | ﹤0.01% |
+5,554
| New | +$440K |
|
|
HOUS
1275
DELISTED
Anywhere Real Estate
HOUS
| $419K | ﹤0.01% |
26,727
-91,239
| -77% | -$1.52M |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Panagora Asset Management held 1,660 positions worth $18.4B, down 2.8% from $18.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Panagora Asset Management's Q1 2022 filing shows 130 new, 801 increased, 372 reduced and 146 closed positions. Its largest new stake was Performance Food Group: 453,149 shares worth $23.1M. The largest sale was JPMorgan Chase, an estimated $76.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Panagora Asset Management's largest Q1 2022 buy was Performance Food Group: 453,149 shares worth $23.1M.
- Panagora Asset Management added most to LyondellBasell Industries in Q1 2022, an estimated $61.5M increase.
- Panagora Asset Management's biggest Q1 2022 reduction was JPMorgan Chase, cutting an estimated $76.2M.
- Panagora Asset Management fully exited Xilinx Inc in Q1 2022, selling an estimated $43.2M.
- Panagora Asset Management's ten largest holdings make up 25% of its $18.4B portfolio in Q1 2022.
- Panagora Asset Management opened 130 new positions and closed 146 in Q1 2022.
- Panagora Asset Management's portfolio value fell 2.8% quarter-over-quarter to $18.4B.
Based on Panagora Asset Management's 13F filing for Q1 2022, filed 12 May 2022.